申请人:Egis Gyogyszergyar
公开号:US05204343A1
公开(公告)日:1993-04-20
The invention relates to the new 1-(3-chlorophenyl)-4-hydroxymethyl-7,8-dimethoxy-5H-2,3-benzodiazepine of formula (I) ##STR1## and pharmaceutically acceptable acid addition salts thereof, furthermore to a process for preparing these compounds. The compounds according to the invention possess valuable anxiolytic, antiaggressive and antidepressant effects and have at the same time favorable acute toxicity values, so they can be used to advantage in therapy.
本发明涉及新的化合物1-(3-氯苯基)-4-羟甲基-7,8-二甲氧基-5H-2,3-苯并二氮平(I)及其药学上可接受的酸盐,还涉及制备这些化合物的方法。本发明的化合物具有宝贵的抗焦虑、抗攻击和抗抑郁作用,同时具有良好的急性毒性值,因此可以在治疗中有优势应用。